Literature DB >> 29795477

The global landscape of cancer cell therapy.

Jun Tang1, Vanessa M Hubbard-Lucey1, Laura Pearce1, Jill O'Donnell-Tormey1, Aiman Shalabi1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29795477     DOI： 10.1038/nrd.2018.74

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  22 in total

Review 1.  Mechanisms of resistance to CAR T cell therapy.

Authors:  Nirali N Shah; Terry J Fry
Journal:  Nat Rev Clin Oncol       Date:  2019-06       Impact factor: 66.675

2.  Metabolic engineering generates a transgene-free safety switch for cell therapy.

Authors:  Volker Wiebking; James O Patterson; Renata Martin; Monica K Chanda; Ciaran M Lee; Waracharee Srifa; Gang Bao; Matthew H Porteus
Journal:  Nat Biotechnol       Date:  2020-07-13       Impact factor: 54.908

Review 3.  The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19.

Authors:  Peter Braendstrup; Bruce L Levine; Marco Ruella
Journal:  Cytotherapy       Date:  2020-02-01       Impact factor: 5.414

4.  Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.

Authors:  Chunyan Yang; Fangfang Chen; Ping Ren; Laren Lofchy; Chun Wan; Jingshi Shen; Guankui Wang; Hanmant Gaikwad; Jessica Ponder; Craig T Jordan; Robert Scheinman; Dmitri Simberg
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

Review 5.  Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy.

Authors:  Michael Byrne; Olalekan O Oluwole; Bipin Savani; Navneet S Majhail; Brian T Hill; Fredrick L Locke
Journal:  Biol Blood Marrow Transplant       Date:  2019-07-04       Impact factor: 5.742

6.  Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy.

Authors:  Jaitip Tipanee; Ermira Samara-Kuko; Thierry Gevaert; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2022-06-16       Impact factor: 12.910

7.  Clickable Methyltetrazine-Indocarbocyanine Lipids: A Multicolor Tool Kit for Efficient Modifications of Cell Membranes.

Authors:  Hanmant Gaikwad; Guankui Wang; Weston J Smith; Keisha L Alexander; Angelo D'Alessandro; Wei Zhang; Enkhtsetseg Purev; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2019-05-03       Impact factor: 4.774

Review 8.  Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.

Authors:  Erik Tambuyzer; Benjamin Vandendriessche; Christopher P Austin; Philip J Brooks; Kristina Larsson; Katherine I Miller Needleman; James Valentine; Kay Davies; Stephen C Groft; Robert Preti; Tudor I Oprea; Marco Prunotto
Journal:  Nat Rev Drug Discov       Date:  2019-12-13       Impact factor: 84.694

9.  Comparative analysis of cell therapy infusion workflows at clinical sites.

Authors:  Adam Joules; Julianne Connors; Rachel Johnson; Elizabeth A Van Orsow; David H McKenna; Sarah Nikiforow; Jerome Ritz; Adrian Gee; Allison Hubel
Journal:  Cytotherapy       Date:  2021-01-30       Impact factor: 6.196

10.  In Vitro Study of Multi-Therapeutic Properties of Thymus bovei Benth. Essential Oil and Its Main Component for Promoting Their Use in Clinical Practice.

Authors:  Sherif T S Hassan; Kateřina Berchová-Bímová; Miroslava Šudomová; Milan Malaník; Karel Šmejkal; Kannan R R Rengasamy
Journal:  J Clin Med       Date:  2018-09-15       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.